Journal of Medicinal Chemistry p. 767 - 786 (2017)
Update date:2022-08-15
Topics:
Jones, Peter
Storer, R. Ian
Sabnis, Yogesh A.
Wakenhut, Florian M.
Whitlock, Gavin A.
England, Katherine S.
Mukaiyama, Takasuke
Dehnhardt, Christoph M.
Coe, Jotham W.
Kortum, Steve W.
Chrencik, Jill E.
Brown, David G.
Jones, Rhys M.
Murphy, John R.
Yeoh, Thean
Morgan, Paul
Kilty, Iain
By use of a structure-based computational method for identification of structurally novel Janus kinase (JAK) inhibitors predicted to bind beyond the ATP binding site, a potent series of indazoles was identified as selective pan-JAK inhibitors with a type 1.5 binding mode. Optimization of the series for potency and increased duration of action commensurate with inhaled or topical delivery resulted in potent pan-JAK inhibitor 2 (PF-06263276), which was advanced into clinical studies.
View MoreZhejiang Sanmei Chemical Industry Co., Ltd
Contact:86-579-87633213
Address:Huchu Industrial Zone, Qingnian Rd., Wuyi County, Zhejiang Prov., China.
Weifang Jahwa Chemical Co.,Ltd
Contact:0086-536-8897731,8897730
Address:No.5166 East Dongfeng Street,Weifang,Shandong,China
Landz International Company Ltd.
Contact:0086-21-58891610
Address:985 Dongfang Road, Pudong, Shanghai 200122 China
Taizhou KEDE Chemical.Co.,Ltd.
Contact:86-576-84613060
Address:Jiangkou Chemical Zoon
Hangzhou Pharma & Chem Co.,Ltd.
Contact:+86-571-87040515
Address:No,139Qingchun Rd
Doi:10.1016/S0040-4039(00)88693-1
(1982)Doi:10.1039/c4ra07058e
(2014)Doi:10.1016/j.carres.2007.06.017
(2007)Doi:10.1016/j.bmcl.2005.02.070
(2005)Doi:10.1016/j.tet.2005.02.069
(2005)Doi:10.1016/j.tetlet.2012.05.127
(2012)